The implications of these findings for our study are that we may also find enhanced migration and invasion in our PCOS group compared to controls, independent of whether IGF-1 antagonist is present, which would imply that pathways other than IGF-1 may also be at play in the association between PCOS and EC. This evidence concerns the gene IGF1 and polycystic ovary syndrome.